pantoprazole has been researched along with Apraxia in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with cerebral palsy are known to have a higher incidence of GORD as well as problems with swallowing, vomiting and recurrent chest infections." | 1.35 | Oral impact of gastro-oesophageal reflux disease: a case report. ( Liberali, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liberali, S | 1 |
1 other study available for pantoprazole and Apraxia
| Article | Year |
|---|---|
Oral impact of gastro-oesophageal reflux disease: a case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Apraxias; Cerebral Palsy; Feeding Behavior | 2008 |